MUZAFFARABAD: With breaking viewership records on digital media, Kashmir Premier League (KPL) has turned into a “global premier league”, said its Director Cricket Operations Taimoor Khan. Talking to ...
LONDON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...
Kiniksa Pharmaceuticals Ltd. Class A ((KNSA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
LONDON, June 05, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...
BEIJING, Nov. 10, 2025 /PRNewswire/ -- The Honor of Kings King Pro League (KPL) 2025 Grand Finals, hosted by Tencent and organized by Hero Esports, came to a triumphant close at Beijing's iconic ...
Kiniksa Pharmaceuticals is set to begin a Phase 2/3 clinical trial for its drug KPL-387, aimed at treating recurrent pericarditis, in mid-2025. The company has noted that data from the ongoing Phase 1 ...
Kiniksa Pharmaceuticals Ltd. Class A (KNSA) announced an update on their ongoing clinical study. Kiniksa Pharmaceuticals recently announced updates to its Phase 2 clinical study, ‘A Phase 2 Posology ...
Kiniksa Pharmaceuticals has delivered strong share price performance this year thanks to a strong start to the year for Arcalyst. Medicare redesign with improved patient affordability has boosted ...
In a fresh setback for Kirloskar Brothers Ltd (KBL), the Bengaluru Commercial Court removed the company from a trademark infringement suit over the ‘Kirloskar’ brand, and instead allowed Kirloskar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback